MedPath

Effects of physical exercise associated with laser therapy on functional capacity and muscle performance in individuals with persistent symptoms of Covid-19

Not Applicable
Conditions
Musculoskeletal Pain
Myalgia
Arthralgia
C01.748.610.763.500
Registration Number
RBR-67wbv3r
Lead Sponsor
niversidade Federal de Santa Catarina - Campus Araranguá
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Individuals aged between 18 and 70 years, of both genders with musculoskeletal pain, myalgia or arthralgia, persisting after four weeks of Covid-19 infection. Individuals with pain rating equal to or greater than 3 on the Visual Analogue Scale. Individuals classified as grade 1, 2 and 3 on the modified Medical Research Council scale

Exclusion Criteria

Individuals with pain rating lower than 3 on the Visual Analogue Scale. Individuals with grades 4 and 5 on the modified Medical Research Council scale. Individuals with chronic pain complaint in the treatment region, prior to Covid-19. Individuals with epilepsy, fibromyalgia, cardiac alterations and decompensated diabetes. Recent surgeries in regions related to the treatment site with less than 3 months; Laser photosensitivity; Continuous use of analgesics, muscle relaxants or anti-inflammatory drugs in the 48 hours prior to the intervention. pregnant women. Individuals with neurological and cognitive dysfunctions, such as dementia, intellectual disability, communicative deficit or any other condition that makes it impossible to understand the study procedures

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the threshold of pain by pressure, using algometry as a method, with an analog algometer. Where we will measure pain intensity in kilogram-force before the first session, after the third session, and after four weeks of treatment. It is expected to find at least a 5% variation in pre- and post-intervention measurements between the intervention and placebo groups
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath